CML is derived from hematopoietic stem cells and the expression of BCR-ABL1 in leukemic stem cells is sufficient to initiate and promote leukemogenesis. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.